In-vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii.
Cirioni
O
O
Giacometti
A
A
Balducci
M
M
Burzacchini
F
F
Scalise
G
G
D017088:AIDS-Related Opportunistic Infections / Q000382:microbiology; D000935:Antifungal Agents / Q000494:pharmacology*; D053626:Atovaquone; D006801:Humans; D008826:Microbial Sensitivity Tests; D009281:Naphthalenes / Q000494:pharmacology*; D009285:Naphthoquinones / Q000494:pharmacology*; D011010:Pneumocystis / Q000187:drug effects*; D011020:Pneumonia, Pneumocystis / Q000382:microbiology; D000077291:Terbinafine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology*
D000935:Antifungal Agents; D009281:Naphthalenes; D009285:Naphthoquinones; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000077291:Terbinafine; D053626:Atovaquone